1. Ability of the 1992 and 1997 American Joint Commission on Cancer staging systems for prostate cancer to predict progression free survival after radial prostatectomy for stage T2 disease;Han;J Urol,2000
2. D'Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, Rhude M, Rocha S, Wein A, Richie JP. A validated system for predicting PSA outcome following radical prostatectomy in the PSA era: 10-year results. J Urol 2001 (in review).
3. Chen M, Tomaszewski JE, Renshaw AA, Wein C, Richie JP. The clinical utility of the percent of positive prostate biopsies in defining biochemical outcome following radical prostatectomy for patients with clinically localized prostate cancer;D'Amico;J Clin Oncol,2000
4. The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external beam radiation therapy for patients with clinically localized prostate cancer;D'Amico;Int J Radiat Oncol Biol Phys,2001
5. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy;Grossfeld;J Urol,2001